Lung transplantation for lymphangioleiomyomatosis

被引:53
|
作者
Pechet, TT
Meyers, BF
Guthrie, TJ
Battafarano, RJ
Trulock, EP
Cooper, JD
Patterson, GA
机构
[1] Washington Univ, Sch Med, Div Cardiothorac Surg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA
来源
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2004年 / 23卷 / 03期
关键词
D O I
10.1016/S1053-2498(03)00195-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Lymphangioleiomyomatosis is a rare disease in women leading to respiratory failure. We describe a single-institution experience with lung transplantation for end-stage lymphangioleiomyomatosis. Methods: We retrospectively reviewed records of patients transplanted for lymphangioleiomyomatosis between 1989 and 2001. Follow-up was-complete on all patients (median 3.5 years). Results: Seven single and 7 bilateral transplants were performed on 14 recipients (mean age 41.8 years). Eleven patients suffered the following intra-operative complications: dysrhythmia (1); blood loss > 1,000 ml (7); extensive pleural adhesions (10); hypothermia (1); phrenic nerve injury (1); and graft dysfunction (2). The following post-operative complications occurred in 11 recipients: dysrhythmia (7); respiratory failure (5); sepsis (3); airway dehiscence (2); vocal cord dysfunction (1); cholecystitis (1); deep vein thrombosis (1); acute renal failure (1); and pericarditis (1). Postoperative chylous fistulas necessitated thoracic duct ligation (1); sclerosis (6); and drainage of ascites (1). There were no peri-operative deaths. Late deaths occurred due to sepsis in 2 patients and obliterative bronchiolitis in 1 patient. Survival rates were 100%, 90% and 69% at (1, 2 and 5 years, respectively.) Mean FEV1 (1.77 +/- 1.06 vs 0.60 +/- 0.91) and 6-minute walk (1,519 +/- 379 vs 826 +/- 293 feet) improved at 1 year as compared with pre-transplant evaluation. Five patients reached criteria for bronchiolitis obliterans syndrome. One recipient has had a documented recurrence of lymphangioleiomyomatosis in the transplanted lung. Conclusions: Early and late survival after lung transplant are comparable in lymphangioleiomyomatosis patients versus patients with other diseases. Morbidity is common after transplant for lymphangioleiomyomatosis and is usually due to lymphangioleiomyomatosis-related complications. Lymph angioleiomyomatosis recurrence in the allograft does not pose a substantial clinical problem.
引用
收藏
页码:301 / 308
页数:8
相关论文
共 50 条
  • [21] Lymphangioleiomyomatosis:: Recurrence after single lung transplantation
    Bittmann, I
    Dose, TB
    Müller, C
    Dienemann, H
    HUMAN PATHOLOGY, 1997, 28 (12) : 1420 - 1423
  • [22] Sirolimus Treatment for Recurrent Lymphangioleiomyomatosis After Lung Transplantation
    Chen, Fengshi
    Omasa, Mitsugu
    Kondo, Nobuyuki
    Fujinaga, Takuji
    Shoji, Tsuyoshi
    Sakai, Hiroaki
    Bando, Toru
    ANNALS OF THORACIC SURGERY, 2009, 87 (01): : E6 - E7
  • [23] Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis
    Ussavarungsi, Kamonpun
    Hu, Xiaowen
    Scott, J. P.
    Erasmus, David B.
    Mallea, Jorge M.
    Alvarez, Francisco
    Lee, Augustine S.
    Keller, Cesar A.
    Ryu, Jay H.
    Burger, Charles D.
    RESPIRATORY MEDICINE, 2015, 109 (10) : 1354 - 1359
  • [24] Lung transplantation in sporadic lymphangioleiomyomatosis: Study of 7 cases
    Ansotegui Barrera, Emilio
    Mancheno Franch, Nuria
    Penalver Cuesta, Juan Carlos
    Vera-Sempere, Francisco
    Padilla Alarcon, Jose
    MEDICINA CLINICA, 2013, 141 (08): : 349 - 352
  • [25] Lung transplantation for cystic lung diseases: Lymphangioleiomyomatosis, histiocytosis X, and sarcoidosis
    Boehler, A
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 22 (05) : 509 - 515
  • [26] Acute Constrictive Pericarditis After Lung Transplantation for Lymphangioleiomyomatosis
    Billings, Martha E.
    Mulligan, Michael
    Raghu, Ganesh
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (01): : 110 - 113
  • [27] Lung Transplantation for Lymphangioleiomyomatosis: A Single-Center Experience
    Korotcenko, Loreta
    Schuurmans, Mace
    Benden, Christian
    Schmitt-Opitz, Isabelle
    Weder, Walter
    Inci, Ilhan
    CHEST, 2017, 152 (04) : 1103A - 1103A
  • [28] Surgical Treatment of Chylothorax After Lung Transplantation for Lymphangioleiomyomatosis
    Gonzalez Garcia, Francisco Javier
    Baamonde Laborda, Carlos
    Munoz Fos, Anna
    Moreno Casado, Paula
    Redel Montero, Javier
    Algar Algar, Javier
    Cerezo Madueno, Francisco
    Poveda Chaves, David
    Ruiz Lopez, Eloisa
    Salvatierra Velazquez, Angel
    Alvarez Kindelan, Antonio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (05): : 335 - 336
  • [29] Peritoneovenous Shunt for Chylous Ascites after Lung Transplantation for Lymphangioleiomyomatosis
    Kanou, T.
    Nakagiri, T.
    Minami, M.
    Inoue, M.
    Shintani, Y.
    Okumura, M.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (05) : 1390 - 1393
  • [30] Recurrence Of Lymphangioleiomyomatosis After Double Lung Transplantation In A Patient With Lam
    Taveira-DaSilva, A. M.
    Jones, A.
    Julien-Williams, P.
    Nathan, S. D.
    Shlobin, O. A.
    Moss, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195